Top Ranked Value Stocks to Buy for March 7th

BPOP OMF

Here are four stocks with buy rank and strong value characteristics for investors to consider today, March 7th:

Celgene Corporation : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 7.8% over the last 60 days.

Celgene has a price-to-earnings ratio (P/E) of 8.04, compared with 18.50 for the industry. The company possesses a Value Score of A.

National General Holdings Corp. : This insurance products and services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.

National General has a price-to-earnings ratio (P/E) of 10.00, compared with 15.90 for the industry. The company possesses a Value Score of A.

Popular, Inc. (BPOP - Free Report) : This mortgage, retail, and commercial banking products and services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.4% over the last 60 days.

Popular has a price-to-earnings ratio (P/E) of 9.18, compared with 13.80 for the industry. The company possesses a Value Score of A.

OneMain Holdings, Inc. (OMF - Free Report) : This consumer finance and insurance products and services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.6% over the last 60 days.

OneMain has a price-to-earnings ratio (P/E) of 5.95, compared with 8.50 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>